Atlas Trials

Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease

Clinical trial NCT01847170 · COMPLETED

Trial details

NCT number
NCT01847170
Sponsor
Beth Israel Deaconess Medical Center
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Crohn's Disease
Start date
2013-05-01
Primary completion
2016-11-01
Enrollment
22

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.